Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

Similar articles for PubMed (Select 18177231)

1.

Can the therapeutic efficacy of tocotrienols in neurodegenerative familial dysautonomia patients be measured clinically?

Rubin BY, Anderson SL, Kapás L.

Antioxid Redox Signal. 2008 Apr;10(4):837-41. doi: 10.1089/ars.2007.1874. Review.

PMID:
18177231
2.

Rectifying RNA splicing errors in hereditary neurodegenerative disease.

Swanson MS.

Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2637-8. doi: 10.1073/pnas.1500976112. Epub 2015 Feb 17. No abstract available.

PMID:
25691745
3.

Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomia.

Yoshida M, Kataoka N, Miyauchi K, Ohe K, Iida K, Yoshida S, Nojima T, Okuno Y, Onogi H, Usui T, Takeuchi A, Hosoya T, Suzuki T, Hagiwara M.

Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2764-9. doi: 10.1073/pnas.1415525112. Epub 2015 Feb 9.

PMID:
25675486
4.

Familial dysautonomia (FD) patients have reduced levels of the modified wobble nucleoside mcm5s2U in tRNA.

Karlsborn T, Tükenmez H, Chen C, Byström AS.

Biochem Biophys Res Commun. 2014 Oct 30;454(3):441-445. doi: 10.1016/j.bbrc.2014.10.116. [Epub ahead of print]

5.

Current treatments in familial dysautonomia.

Palma JA, Norcliffe-Kaufmann L, Fuente-Mora C, Percival L, Mendoza-Santiesteban C, Kaufmann H.

Expert Opin Pharmacother. 2014 Dec;15(18):2653-71. doi: 10.1517/14656566.2014.970530. Epub 2014 Oct 17. Review.

6.

Dynamic changes in IKBKAP mRNA levels during crisis of familial dysautonomia patients.

Cheishvili D, Laiba E, Rekhtman D, Claman A, Razin A, Maayan C.

Auton Neurosci. 2014 Feb;180:59-65. doi: 10.1016/j.autneu.2013.10.009. Epub 2013 Nov 1.

PMID:
24268683
7.

Phosphatidylserine increases IKBKAP levels in a humanized knock-in IKBKAP mouse model.

Bochner R, Ziv Y, Zeevi D, Donyo M, Abraham L, Ashery-Padan R, Ast G.

Hum Mol Genet. 2013 Jul 15;22(14):2785-94. doi: 10.1093/hmg/ddt126. Epub 2013 Mar 20.

8.

Familial dysautonomia (Riley-Day syndrome): when baroreceptor feedback fails.

Norcliffe-Kaufmann L, Kaufmann H.

Auton Neurosci. 2012 Dec 24;172(1-2):26-30. doi: 10.1016/j.autneu.2012.10.012. Epub 2012 Nov 20. Review.

PMID:
23178195
9.

Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression.

Lee G, Ramirez CN, Kim H, Zeltner N, Liu B, Radu C, Bhinder B, Kim YJ, Choi IY, Mukherjee-Clavin B, Djaballah H, Studer L.

Nat Biotechnol. 2012 Dec;30(12):1244-8. doi: 10.1038/nbt.2435. Epub 2012 Nov 25.

10.

IKAP expression levels modulate disease severity in a mouse model of familial dysautonomia.

Dietrich P, Alli S, Shanmugasundaram R, Dragatsis I.

Hum Mol Genet. 2012 Dec 1;21(23):5078-90. doi: 10.1093/hmg/dds354. Epub 2012 Aug 24.

11.

Case scenario: perioperative administration of tocotrienols and green tea extract in a child with familial dysautonomia.

Cook-Sather SD, Viola L, Zur KB, Rubin BY.

Anesthesiology. 2012 Sep;117(3):639-45. No abstract available.

PMID:
22850346
12.

Nutraceutical-mediated restoration of wild-type levels of IKBKAP-encoded IKAP protein in familial dysautonomia-derived cells.

Anderson SL, Liu B, Qiu J, Sturm AJ, Schwartz JA, Peters AJ, Sullivan KA, Rubin BY.

Mol Nutr Food Res. 2012 Apr;56(4):570-9. doi: 10.1002/mnfr.201100670.

PMID:
22495984
13.

Deletion of exon 20 of the Familial Dysautonomia gene Ikbkap in mice causes developmental delay, cardiovascular defects, and early embryonic lethality.

Dietrich P, Yue J, E S, Dragatsis I.

PLoS One. 2011;6(10):e27015. doi: 10.1371/journal.pone.0027015. Epub 2011 Oct 28.

14.

Kinetin improves IKBKAP mRNA splicing in patients with familial dysautonomia.

Axelrod FB, Liebes L, Gold-Von Simson G, Mendoza S, Mull J, Leyne M, Norcliffe-Kaufmann L, Kaufmann H, Slaugenhaupt SA.

Pediatr Res. 2011 Nov;70(5):480-3. doi: 10.1038/pr.2011.705.

15.

IKAP/Elp1 involvement in cytoskeleton regulation and implication for familial dysautonomia.

Cheishvili D, Maayan C, Cohen-Kupiec R, Lefler S, Weil M, Ast G, Razin A.

Hum Mol Genet. 2011 Apr 15;20(8):1585-94. doi: 10.1093/hmg/ddr036. Epub 2011 Jan 27.

16.

Phosphatidylserine increases IKBKAP levels in familial dysautonomia cells.

Keren H, Donyo M, Zeevi D, Maayan C, Pupko T, Ast G.

PLoS One. 2010 Dec 29;5(12):e15884. doi: 10.1371/journal.pone.0015884.

17.

Chasing a disease to the vanishing point.

Couzin-Frankel J.

Science. 2010 Apr 16;328(5976):298-300. doi: 10.1126/science.328.5976.298. No abstract available.

PMID:
20395489
18.

Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence.

Meyer JH, Wilson AA, Sagrati S, Miler L, Rusjan P, Bloomfield PM, Clark M, Sacher J, Voineskos AN, Houle S.

Arch Gen Psychiatry. 2009 Dec;66(12):1304-12. doi: 10.1001/archgenpsychiatry.2009.156.

PMID:
19996035
19.

Chest computed tomography findings in familial dysautonomia patients: a model for aspiration.

Hiller N, Simanovsky N, Bahagon C, Bogot N, Maayan C.

Isr Med Assoc J. 2009 Jul;11(7):393-7.

20.

Diabetes mellitus and long-term outcome in heart failure patients after surgical ventricular restoration.

Castelvecchio S, Ranucci M, Di Donato M, Menicanti L.

Ann Thorac Surg. 2009 Nov;88(5):1451-6. doi: 10.1016/j.athoracsur.2009.07.006.

PMID:
19853091
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk